Biobanking Services Market

Biobanking Services Market is segmented By Service Type (Human Tissue Biobanking, Stem Cell Biobanking, DNA/RNA Biobanking, Cord Biobanking, Other Services), By Sample Type (Blood Products, Human Tissues, Cell Lines, Nuclei Acids), By Application (Regenerative Medicine, Life Science, Clinical Research), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029.

 

Biobanking Services Market is expected to grow at a CAGR of 4.6% during the forecasting period ( 2022-2029).

A biobank is a type of biorepository which helps in storing biological samples (usually human) such as blood, urine, and others for use in research. Researchers can access the data of a large number of people through biobanks. Multiple researchers use samples in biobanks and the data derived from those samples for research studies and other purposes. Growing usage of these biobanks for various purposes is expected to boost the global biobanking services market over the forecast period ( 2022-2029).

Biobanking Services Market Dynamics 

Growing prevalence of chronic diseases, such as cancer and cardiovascular diseases, and the use of these blood biomarkers for the detection of various types of cancers is one of the major factors driving the global biobanking services market. According to the Leukemia & Lymphoma Society, in 2017, approximately every 3 minutes, one person in the United States (US) is diagnosed with blood cancer.

Additionally, these samples from biobanks are used for various purposes, such as research, therapeutics, clinical trials, and drug development. This has led to an increase in funding by many non-profit and government organizations for the establishment of more public storage biobanks. For instance, in 2017, National Institutes of Health-funded $2.1 million to the CFS biobank, which represents a considerable investment in biomedical research. Thus, the rise in funds for biobanks is expected to propel the biobanking market growth.

However, factors like cost constraints, limited access, and information sharing are hampering the global biobanking services market. 

Biobanking Services Market Segmentation

Based on the sample type, the global biobanking services market is broadly segmented as blood products, human tissues, cell lines, nuclei acids. Among all these blood products accounted for a major market share in 2018 and are expected to grow at a significant pace during the forecast period (2019-2026). It is owing to the rising incidence of blood disorders and the increasing demand for various types of blood products worldwide. According to the Leukemia & Lymphoma Society, in 2018, an estimated total of 174,250 people in the US are diagnosed with leukemia, lymphoma, or myeloma. Thus, growth blood disorders are expected to drive the blood products segment in the global biobanking services market.

Biobanking Services Market Scope

Metrics	Details
Market CAGR	4.6%
Segments Covered	By Service Type, By Sample Type, By Application, and By Region
Report Insights Covered	Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.
Fastest Growing Region	Asia Pacific
Largest Market Share	North America

Biobanking Services Market Geographical Analysis 

The global Biobanking Services market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America region accounted for major market share in 2018 and is projected to grow at a high CAGR over the forecast period (2019-2026). It is owing to factors like growing research activities in regenerative medicine, cell, and gene therapy. Additionally, the United States has the largest expenditure for R&D and better healthcare infrastructure in the world. Different pharmaceutical/ biotech companies, academia, and research institutes are utilizing biobanks for the storage of DNA, RNA, tissue, serum, blood, plasma, cells, etc. According to the Hastings Center, in 2017, 300 million biospecimens have been stored in the United States in various public and private biobanks. 

Biobanking Services Market Competitive Analysis 

Significant players of the global biobanking services are Alpha Cord Inc., Autogen Inc., BioCision, Biokryo GmbH, BioLife Solutions Inc., Biomatrica Inc., BioStorage Technologies Inc., Cells4Life Ltd., Cryo Bio System, and others. Majority of these prominent players are adopting a few organic and inorganic strategies such as product launches, collaboration, and product agreements, and other key developments to enhance their product portfolio in the biobanking services market. For instance, in February 2019, The Stanford Biobank launched a state-of-art biospecimen management system.

In 2018, AutoGen, Inc., one of the leading providers of nucleic acid extraction equipment, installed 13 advanced automated DNA extraction solutions.

In May 2015, BioCision, LLC, and Brooks Automation announced the launch of CryoPod™ Carrier, a jointly developed liquid nitrogen (LN2)-based system for the safe, reliable, and protected handling and transport of cryogenic biospecimens.

Trending Topics

Apheresis Market

Stomach Cancer Treatment Market

Apoptosis Assays Market

FAQ

1.  What is the biobanks market growth?

A. The global biobanks market is expected to grow at a compound annual growth rate of 4.6% from 2022 to 2029 to reach USD 100.8 billion by 2029.

2.  Who are the key players in the biobanks market?

A. Some key players operating in the biobanks market include Thermo Fisher Scientific, Inc.; Merck KGaA; Qiagen; Hamilton Company; VWR International, LLC; Tecan Trading AG.; Danaher; BioCision; Charles River; Lonza; Biovault; and STEMCELL Technologies Inc.

3.  What are the factors driving the biobanks market?

A. Key factors that are driving the biobanks market growth are the increasing popularity of fertility preservation services, investment in facility expansion for biobanking, and growing collaborations between biobanks and end-users.